2007
DOI: 10.1111/j.1365-2796.2007.01818.x
|View full text |Cite
|
Sign up to set email alerts
|

Acute liver failure in Sweden: etiology and outcome

Abstract: Abstract. Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, Sangfelt P, Danielsson Å , Sandberg-Gertzén H, Lööf L, Prytz H, Björnsson E (Sahlgrenska University Hospital, Gothenburg; Karolinska University Hospital, Huddinge, Stockholm; University Hospital MAS, Malmö; University Hospital, Linköping; University Hospital, Uppsala; University Hospital, Umeå; University Hospital, Ö rebro; Central Hospital, Västerås; and University Hospital, Lund; Sweden). Acute liver failure in Sweden: etiology and o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
144
4
5

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 170 publications
(164 citation statements)
references
References 15 publications
6
144
4
5
Order By: Relevance
“…This distinction is neither useful nor feasible in the majority of cases always, due to the absence of specific useful features, as pointed out by Björnsson et al [4], Suzuki et al [1], and recently stressed by Weiler-Normann and Schramm [13]. In this setting, the criteria that argue for DI-AIH are the absence of fibrosis at histological examination and the absence of recurrence after discontinuation of immunosuppressive therapy.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…This distinction is neither useful nor feasible in the majority of cases always, due to the absence of specific useful features, as pointed out by Björnsson et al [4], Suzuki et al [1], and recently stressed by Weiler-Normann and Schramm [13]. In this setting, the criteria that argue for DI-AIH are the absence of fibrosis at histological examination and the absence of recurrence after discontinuation of immunosuppressive therapy.…”
Section: Discussionmentioning
confidence: 97%
“…It is also the principal reason of medications withdrawal from the market [2], and the most common cause of fulminant hepatic failure in both the United States and Europe [3,4]. More than 1000 different drugs and herbal products have been described as cause of DILI, with a dose-dependent, or more frequently, an idiosyncratic toxicity.…”
Section: Introductionmentioning
confidence: 99%
“…Paracetamol (acetaminophen) hepatotoxicity remains the leading cause of acute liver failure (ALF) in the UK, North America and Europe, and represents a significant healthcare burden [1][2][3]. Management of early, non-staggered, paracetamol overdose using N-acetyl cysteine (NAC) as an antidote is based upon the use of the Prescott nomogram [4], but this nomogram cannot be used in patients who have taken repeated supratherapeutic ingestions of paracetamol (staggered overdoses), and there are too few data available to conclude that it is reliable in patients who present >15 h post overdose [5].…”
Section: Introductionmentioning
confidence: 99%
“…In the overdose situation, it may cause hepatotoxicity and fulminant hepatic failure. It is the main drug causing acute liver failure in some countries such as the United States, United Kingdom and other European countries (1)(2)(3) . According to the report of the adverse event reporting system of FDA in the United States between 1998 and 2005, paracetamol ranked 5th among drugs suspected of causing any serious non-fatal and fatal adverse reactions (4) .…”
Section: Introductionmentioning
confidence: 99%